Table 4 Study outcomes
Area in the continuum of care | Outcome to be evaluated |
|---|---|
NB. Analysis to be done separately for home and health facility births | |
Antenatal care | • % of pregnant women attending ANC two, four or more times |
• % of pregnant women who know at least two danger signs of pregnancy | |
• % of pregnant women who prepare for birth* | |
• IPT in pregnancy | |
• ITN use in pregnancy | |
• Tetanus toxoid coverage | |
• Uptake of VCT % of mothers who tested for HIV during pregnancy | |
• Uptake of IPT - by number of doses | |
Intrapartum care | • % of pregnant women who have a supervised delivery |
• % of pregnant women who deliver at a health unit | |
• % of babies whose cord was cut with a clean instrument | |
• % of babies who are immediately dried at birth | |
• % of babies who are immediately wrapped after birth | |
• % of babies who are born on a clean surface | |
• % of home births attended by two assistants | |
• % of women who went to the HC in an emergency | |
Postnatal care | • % of babies whose cord was cut with a clean instrument |
• % of babies who are initiated on breastfeeding within one and twenty-four hours of birth | |
• % of babies who are exclusively breastfed during the neonatal period | |
• % of babies whose first bath was delayed for six and twenty-four hours | |
• % of mothers who put nothing on the cord | |
• % of mothers who know at least three neonatal danger signs | |
• % of babies who are immediately dried at birth | |
• % of babies who are immediately wrapped after birth | |
• % of babies who are born on a clean surface | |
• % of home births attended by two assistants | |
• % women whose children were managed in skin-to-skin contact after delivery | |
• mothers who received counselling regarding family planning by six weeks postnatally | |
• % of babies who were taken for care if they were ill | |
• % of babies referred to health facility by CHW that reach, and timeliness of reaching | |
Impact level | newborn deaths and stillbirths (note not powered to measure significant reduction in NMR) but we will explore each maternal and newborn death using the VASA and case–control study for, for example, intervention efficacy. |
Neonatal mortality rates will be calculated by intervention and comparison areas |